Ivy Cosmetics Corporation
Notice Regarding Recognition of Benefit for Adjustment of Corporate Taxes on November 5, 2026 and Revision of Earnings Forecast
Revised the earnings forecast for the interim period of the fiscal year ending March 2027. Net sales raised to 1,513 million yen, operating income to 218 million yen, ordinary income to 214 million yen, and interim net income to 226 million yen. The primary causes are recovery of profitability amid rising material costs and natural disasters, and recognition of a deferred tax asset leading to a benefit for adjustment of corporate taxes. Full-year outlook is under review.
Key Figures
- Net Sales: 1,513 million yen
- Operating Income: 218 million yen
- Ordinary Income: 214 million yen
- Interim Net Income: 226 million yen
- Interim Net Income per Share: 33.84 yen
AI要約
Revision of Earnings Forecast and Causes
The revision announced today includes the expected recognition of a benefit for adjustment of corporate taxes in the interim period of the fiscal year ending March 2027 and upward revisions to net sales and each profit item based on recent performance trends. Despite continued instability from rising material and raw material prices and natural disasters, profitability has recovered, resulting in a substantial upward revision of interim net income and a marked increase in interim net income per share. The full-year earnings forecast is currently under review and will be disclosed again if necessary.
Impact on Shareholders and Outlook
The upward revisions relate to interim performance and are also affected by the impact of recognizing a deferred tax asset. Since the full-year outlook is undecided, attention should be paid to future disclosures. There is no information in this disclosure indicating changes to capital policy or dividend policy.
Ivy Cosmetics Corporation
Company overview · Stock price · Financial data · All IR